Which of the following electrolyte imbalances is least likely to be observed in Chronic Renal Failure (CRF)?
What is the initial treatment of choice for managing secondary hyperparathyroidism in patients with renal osteodystrophy?
In which of the following conditions is hypomagnesemia not typically observed?
What is the most common presentation for IgA nephropathy?
What is the frequency of renal involvement in Henoch-Schönlein purpura (HSP)?
Renal vein thrombosis is associated with all of the following conditions except:
Most common cause of nephrotic syndrome in adults?
Which of the following is NOT a feature of hypernatremia?
In diabetic nephropathy, all of the following are true, except:
Which is the most common symptom of medullary sponge kidney disease?
Explanation: ***Hypercalcemia*** - In **chronic renal failure (CRF)**, the kidneys' inability to activate vitamin D leads to impaired calcium absorption and **hypocalcemia** [1], [2]. - Additionally, the kidneys fail to excrete phosphate, leading to **hyperphosphatemia**, which further exacerbates hypocalcemia by forming calcium-phosphate precipitates [1]. *Hyperkalemia* - **Hyperkalemia** is a common and serious complication of CRF due to the kidneys' impaired ability to excrete **potassium**. - This is exacerbated by conditions like **metabolic acidosis** and certain medications. *Hyperphosphatemia* - In CRF, the kidneys are unable to adequately excrete **phosphate**, leading to an accumulation of **phosphate** in the blood [1]. - This condition directly contributes to **secondary hyperparathyroidism** and bone disease [1], [2]. *Hypocalcemia* - **Hypocalcemia** is very common in CRF, primarily due to decreased production of **calcitriol (active vitamin D)** by the failing kidneys [2]. - Reduced calcitriol leads to lower intestinal **calcium absorption** and impaired bone mineralization [1].
Explanation: ***Phosphate binders*** - **Phosphate binders** are the initial treatment because **hyperphosphatemia** is the primary driver of secondary hyperparathyroidism in renal disease, triggering parathyroid hormone (PTH) release [1]. - They work by binding dietary phosphate in the gastrointestinal tract, preventing its absorption and thus lowering serum phosphate levels [1]. *Cinacalcet* - **Cinacalcet** is a calcimimetic that increases the sensitivity of calcium-sensing receptors on the parathyroid gland, reducing **PTH secretion** [1]. - It is often used if **phosphate binders** and **vitamin D analogs** are insufficient in controlling PTH, making it a second-line treatment [1]. *Bisphosphonates* - **Bisphosphonates** are used to treat osteoporosis by inhibiting osteoclast activity and reducing bone resorption. - They are generally contraindicated in advanced renal osteodystrophy due to concerns about adynamic bone disease and are not an initial treatment for **secondary hyperparathyroidism**. *Calcium restriction* - While restricting dietary calcium might seem intuitive, **hypocalcemia** is often a problem in renal disease due to impaired vitamin D activation [1]. - Overly restricting calcium can worsen hypocalcemia, which would further stimulate PTH release, thus it is not an initial treatment for **secondary hyperparathyroidism**.
Explanation: Diabetes mellitus - While hypomagnesemia can occur in poorly controlled diabetes due to osmotic diuresis, it is not a typical or defining feature of the condition itself in the same way as other options. - Many individuals with controlled diabetes may have normal magnesium levels, and it's often associated with complications rather than the primary disease process. Diarrhea - Chronic or severe diarrhea leads to significant gastrointestinal losses of electrolytes, including magnesium. - This is a common cause of hypomagnesemia, as the body loses fluids and minerals before they can be absorbed. Gitelman syndrome - This is a renal tubular disorder characterized by a defect in the thiazide-sensitive Na-Cl cotransporter in the distal convoluted tubule. - It leads to hypomagnesemia (due to increased renal excretion) and hypokalemia, along with metabolic alkalosis. Bartter syndrome - This syndrome involves a defect in the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle. - It results in significant renal wasting of magnesium [1], leading to hypomagnesemia, along with hypokalemia and metabolic alkalosis.
Explanation: ***Repeated gross hematuria*** - The hallmark of **IgA nephropathy** is recurrent episodes of **gross hematuria**, particularly following **respiratory infections** [1]. - It is often associated with **renal impairment** but can present initially with **visible blood** in the urine [1]. *Nephritic syndrome* - While IgA nephropathy can lead to nephritic features, it does not commonly present primarily as **nephritic syndrome**, which includes hypertension and edema. - Nephritic syndrome is characterized by significant **proteinuria** and acute renal failure, rather than the classic presentation of hematuria [2]. *Microscopic hematuria* - Although **microscopic hematuria** can occur in IgA nephropathy, it is not the most common and noticeable presentation; **gross hematuria** is more characteristic [1]. - Microscopic hematuria lacks the acute visual symptoms seen in cases proving the diagnosis. *Nephritic syndrome* - This option is a repetition of and does not provide any additional unique characteristics specific to **IgA nephropathy**. - It shares the same clinical features discussed previously and is thus not representative of the most common presentation.
Explanation: ***40-60%*** - Renal involvement in Henoch-Schönlein purpura (HSP) is common, affecting approximately **40-60% of patients**. - Renal complications can range from microscopic hematuria to proteinuria, and in some cases, **progressive glomerulonephritis** leading to renal failure. *25-35%* - This percentage underestimates the actual frequency of **renal complications** in HSP. - While mild symptoms might fall within this range, a broader spectrum of renal manifestations is observed. *60-80%* - This percentage overestimates the reported frequency of **renal involvement** in HSP. - Although it is common, a majority of patients do not develop renal symptoms. *5-10%* - This range is too low for the frequency of **renal involvement** in HSP. - Even though it's benign in many cases, some form of renal pathology like hematuria is quite frequent.
Explanation: **Trauma** - While trauma to the abdomen can cause **renal injury** and other vascular issues, isolated **renal vein thrombosis** is not a common direct association or complication [1]. - Renal vein thrombosis typically results from conditions that lead to a **hypercoagulable state** or local vascular stasis. *Sickle cell anemia* - Individuals with **sickle cell anemia** are prone to **vaso-occlusive crises** from sickled red blood cells obstructing blood flow [2]. - This can lead to **renal medullary ischemia** and infarction, making them highly susceptible to **renal vein thrombosis**. *Nephrotic syndrome* - **Nephrotic syndrome** is a significant risk factor for **renal vein thrombosis** due to the urinary loss of **antithrombin III**, a natural anticoagulant. - This loss creates a **hypercoagulable state**, increasing the likelihood of thrombus formation in renal veins. *Dehydration* - Severe **dehydration** leads to **hemoconcentration** (increased blood viscosity) and reduced blood flow. - These factors promote a **hypercoagulable state**, increasing the risk of thrombotic events, including **renal vein thrombosis**, especially in vulnerable populations like infants or the elderly.
Explanation: ***Membranous glomerulonephritis*** - Membranous glomerulonephritis is the **most common cause of nephrotic syndrome** in adults, often associated with **autoimmune diseases** or certain medications. [1] - Patients typically present with **heavy proteinuria**, edema, and a normal renal function in early stages. *Focal GN* - Focal glomerulosclerosis typically affects young individuals and may not usually present as nephrotic syndrome. - It is associated with **obesity** and **HIV**, often leading to more significant renal impairment compared to membranous glomerulonephritis. [1] *Acute GN* - Acute glomerulonephritis generally presents with **hematuria**, **hypertension**, and **renal failure**, rather than nephrotic syndrome. [1] - It can have different causes, such as infections or systemic diseases, but is not the primary condition leading to nephrotic syndrome in adults. *Minimal change disease* - Minimal change disease is more prevalent in **children** [1], and while it can occur in adults, it is less common as a cause of nephrotic syndrome in this demographic. - It is characterized by **responsive edema** to steroids, but its incidence is not as high as membranous glomerulonephritis in adults.
Explanation: Muscle weakness due to hypokalemia - **Hypernatremia** does not directly cause **hypokalemia**; these are distinct electrolyte imbalances. Muscle weakness in hypernatremia is more likely due to direct effects on cell excitability rather than low potassium. - While muscle weakness can occur in severe hypernatremia, it is not typically attributed to **hypokalemia**, making this statement inaccurate as a direct feature of hypernatremia. *Convulsions* - Severe **hypernatremia** leads to cellular dehydration, especially in brain cells, which can cause significant neurological symptoms including **convulsions**. - The rapid fluid shifts across the blood-brain barrier due to high extracellular osmolality can disrupt neuronal function, leading to seizures. *Elevated intracranial tension* - **Hypernatremia** causes water to shift out of brain cells into the hyperosmolar extracellular fluid, leading to **brain shrinkage** rather than elevated intracranial tension [1]. - This cellular dehydration reduces brain volume, which would typically lower, not elevate, intracranial tension [1]. *Altered mental status* - **Hypernatremia** causes significant neurological dysfunction due to cellular dehydration in the brain. - This can manifest as various degrees of **altered mental status**, from lethargy and confusion to coma.
Explanation: ***Insulin requirement becomes high*** - In advanced diabetic nephropathy, especially when renal function significantly declines, the **kidneys' ability to metabolize and excrete insulin decreases**. - This leads to a **prolonged half-life of insulin in the body**, often resulting in a *reduction* in required insulin doses as the disease progresses, rather than an increase. *Cardiovascular abnormalities can occur* - **Diabetic nephropathy** is a major risk factor for developing **cardiovascular disease**, including **hypertension**, atherosclerosis, and heart failure [3]. - The coexistence of these conditions accelerates disease progression and increases morbidity and mortality in diabetic patients [2]. *Micro and macro albuminuria can occur* - **Diabetic nephropathy** characteristically begins with **microalbuminuria** (small amounts of albumin in the urine), which is an early sign of kidney damage [1]. - As the disease progresses, it often advances to **macroalbuminuria** (larger amounts of albumin), indicating more severe kidney damage [1]. *ACE inhibitors can reduce micro albuminuria* - **Angiotensin-converting enzyme (ACE) inhibitors** are a cornerstone of treatment for diabetic nephropathy due to their **renoprotective effects**. - They effectively reduce **glomerular hydrostatic pressure** and **albuminuria**, thereby slowing the progression of kidney disease.
Explanation: ***UTI*** - **Medullary sponge kidney disease** often leads to **urinary stasis** within the dilated collecting ducts, creating a favorable environment for **bacterial growth** and recurrent **urinary tract infections (UTIs)** [1]. - The abnormal kidney structure and presence of stones can also cause **obstruction**, further increasing the risk of UTIs [1], [2]. *Anuria* - **Anuria**, the absence of urine production, is a severe symptom usually indicative of **acute kidney injury** or **bilateral urinary obstruction**. - While medullary sponge kidney can lead to complications, **anuria** is a rare initial or primary presentation. *Anemia* - **Anemia** in kidney disease is typically associated with **chronic kidney disease** stages where there is reduced **erythropoietin production**. - Medullary sponge kidney alone does not commonly cause significant **anemia**, unless it progresses to advanced chronic kidney disease, which is not its most common presentation. *Azotemia* - **Azotemia** refers to elevated levels of **nitrogenous waste products** (like urea and creatinine) in the blood, indicating **impaired kidney function**. - While medullary sponge kidney can sometimes lead to impaired function due to recurrent infections or stones, **azotemia** is not the most common direct symptom; **UTIs** are more frequent [2].
Acute Kidney Injury
Practice Questions
Chronic Kidney Disease
Practice Questions
Glomerular Diseases
Practice Questions
Tubulointerstitial Diseases
Practice Questions
Nephrotic and Nephritic Syndromes
Practice Questions
Urinary Tract Infections
Practice Questions
Renal Replacement Therapy
Practice Questions
Fluid and Electrolyte Disorders
Practice Questions
Acid-Base Disorders
Practice Questions
Kidney in Systemic Diseases
Practice Questions
Kidney Stones and Obstructive Uropathy
Practice Questions
Hypertension in Kidney Disease
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free